Once-Weekly Semaglutide in Adolescents with Obesity # Article Summary This article summarizes the findings of the STEP (Semaglutide Treatment Effect in People with Obesity) TEEN clinical trial to evaluate once-weekly semaglutide in adolescents
Manevich Y, Feinstein SI, Fisher AB (2004) Activation of the antioxidant enzyme 1-CYS peroxiredoxin requires glutathionylation mediated by heterodimerization with GST
40 Due to the deidentified nature of these databases, however, none of these large-scale cohort studies could account for treatment adherence and duration of exposure, and they lacked access to ophthalmic examination data
Unverified GLP-1-Related Claims Flood Food, Supplement Markets Social media influencer Tamie Konzier was on a mission to lose weight when she started taking the dietary supplement GLP-Activate
The 2-monoacylglycerol moiety of dietary fat appears to be responsible for the fat-induced release of GLP-1 in humans
By last August, the FDA logged a reported shortage of the drug due to an increase in demand